Scholar Rock Holding Corporation received FDA approval for its drug ISEMBYLD (apitegromab) to treat spinal muscular atrophy (SMA) in patients aged 2 years and older. This approval opens a market opportunity exceeding $2 billion, with potential growth into younger patients, subcutaneous versions, and new diseases like facioscapulohumeral muscular dystrophy (FSHD). The company plans to resubmit its marketing authorization application in Europe and file for approval in Japan by the end of 2026, supported by a validated manufacturing facility. Scholar Rock currently holds $492.1 million in cash to fund operations through the second half of 2027 but may raise additional capital as commercialization progresses. Pricing and reimbursement remain key risks to watch.
Scholar Rock's recent FDA approval for its SMA drug is the subject, with Pluang's health sector data providing market context. As of Sep 16, 2026 02:01 WIB, among 91 priced US health-sector stocks on Pluang, 24 advanced while 66 declined. Notable movers include BBIO at USD 68.51 with a -5.35% change, NBIX at USD 149.47 down 4.93%, and FLNA at USD 0.69 falling 4.66%.
TSMC reports that demand for AI chips remains significantly higher than its production capacity. This supply-demand gap highlights the strong growth potential in the AI semiconductor market. As a result, investors see Nvidia, a leading AI chipmaker, ...
JinkoSolar introduced the Tiger Neo 5.0, an all-black residential solar module featuring new TAC technology that delivers up to 510 W power and 25.52% efficiency. Designed for premium homes, it offers a deeper black appearance and improved energy yie...
Circle's USD Coin (USDC) circulation decreased by about 500 million tokens, or 0.7%, in the week ending October 15, with redemptions totaling $11.4 billion surpassing new issuance of $10.9 billion. Circulation stood at 72.5 billion USDC, down from 73...
Arbitrum has introduced a USDG stablecoin growth program backed by a 2 million ARB token reward pool aimed at increasing stablecoin liquidity on its layer-2 blockchain network. This initiative incentivizes users to adopt USDG by tying rewards directl...
York Water has paid uninterrupted dividends since 1816, showcasing exceptional dividend consistency. The utility's strategy of capital spending, organic growth, and acquisitions supports potential earnings growth. With an A- S&P credit rating and sta...
